Cat Vaccines Market Size, Share, Growth – By Vaccine Type, By Disease Type, By Route of Administration, By Component, By Duration of Immunity – Global Forecast, 2025 – 2034

Cat Vaccines Market Size

The global cat vaccines market size was valued at USD 1.1 billion in 2024 and is estimated to grow at a CAGR of 9.2% from 2025 to 2034. The growth of the market is fueled by several key factors, including the increasing awareness of animal healthcare and the rising number of pet owners worldwide.
 

Vaccination is crucial for protecting cats against various diseases like feline leukemia, feline panleukopenia, feline respiratory diseases, and rabies, which are prevalent in both domestic and stray cat populations. As more pet owners recognize the importance of preventive healthcare for their cats, the demand for vaccines has surged.
 

Additionally, the increasing focus on zoonotic diseases, which can be transmitted between animals and humans, has led to heightened awareness about the necessity of vaccinations in preventing such diseases, especially rabies. Thus, these factors are collectively contributing to the increased adoption of companion animal vaccines including cat vaccines, thereby driving the market growth. Moreover, the increased adoption of pet insurance and pet care products and services further supports the market expansion.
 

Cat vaccines are a subset of animal vaccines designed to protect companion animals, particularly cats, from various infectious diseases. These vaccines include vaccines, such as those for feline leukemia and feline respiratory diseases, as well as vaccines for less common conditions like rabies. By stimulating the immune system, cat vaccines help prevent the spread of these diseases, ensuring the health and well-being of domestic and outdoor cats.
 

Cat Vaccines Market Trends

Increasing pet ownership and rising expenditures on pet health are key trends driving the growth of the market.
 

• According to People's Dispensary for Sick Animals (PDSA), in UK 11 million pet cats are owned by 24% of the adult population, reflecting strong pet ownership rates in 2023. As more people consider cats part of their family, they invest in preventive healthcare to ensure their cats' well-being.
   
• This includes regular vaccines and routine testing to protect against diseases such as Feline Leukemia and Rabies, especially as 90% of cats in Britain have outdoor access, which increases their exposure to pathogens.
   
• Additionally, as per the Humane Society of Huron Valley, spending on cat health is also rising, with owners typically spending between USD 65 – USD 150 annually for vaccines and check-ups, and potentially up to an additional USD 350 for outdoor cats who require more comprehensive care like heartworm, flea/tick preventatives, and additional vaccinations.
   
• This trend of increased spending reflects a greater awareness of pet health needs and a growing willingness to invest in preventive measures. Thus, the demand for comprehensive vaccine options is steadily increasing, thereby fueling the growth of the market.
   

Cat Vaccines Market Analysis

Based on vaccine type, the global market is segmented into modified/attenuated live, inactivated, and other vaccine types. The modified/attenuated live segment accounted for highest market share of 50.5% in 2024.
 

• The growth of the segment is primarily driven by its high efficacy, robust immune response, and cost-effectiveness, making it a top choice for veterinarians and pet owners.
   
• Additionally, these vaccines provide strong, long-lasting immunity against severe and prevalent feline diseases like feline leukemia, feline panleukopenia, and feline respiratory diseases, thereby driving its adoption.
   
• Moreover, their rapid onset of immunity is especially valuable in high-risk settings, such as shelters, where disease can spread quickly, helping meet the rising demand for effective, convenient preventive care in cats.
   

Based on disease type, the cat vaccines market is categorized into feline leukemia, feline panleukopenia (feline distemper), feline respiratory diseases, feline rabies, and other disease types. The feline respiratory diseases segment dominated the market and was valued at USD 363.7 million in 2024.
 

• Feline respiratory diseases, including Feline Herpesvirus (FHV) and Feline Calicivirus (FCV), are highly contagious and common among cats, especially in multi-cat environments like shelters.
   
• These diseases cause severe symptoms, such as breathing difficulties, fever, and reduced appetite, with risks of chronic complications, driving strong demand for preventive vaccines to ensure long-term feline health.
   
• Veterinarians’ recommendations for respiratory vaccines as core vaccinations have further boosted demand, as they are vital for protecting both indoor and outdoor cats.
   
• This combination of high prevalence, serious health impact, and focus on preventive care has led the respiratory diseases segment to dominate the market.

Based on route of administration, the cat vaccines market is divided into injectables and intranasal. The injectables segment held the highest market share and is expected to grow at 9% CAGR over the analysis period.
 

• The dominance of injectables segment is due to its high efficacy, rapid immune response, and widespread veterinary recommendation.
   
• Injectable vaccines offer reliable, long-lasting immunity and are easy to administer in clinical settings, making them an essential part of routine feline healthcare.
   
• Additionally, the availability of combination injectable vaccines, which protect against multiple diseases in a single dose, appeals to pet owners looking for comprehensive, convenient options.
   
• These advantages have made injectables the preferred choice in feline vaccinations, securing their leading market position.
   

Based on component, the global cat vaccines market is classified into combined vaccine and mono vaccine. The combined vaccine dominated the market with USD 643.1 million revenue in 2024.
 

• Combined vaccines offer protection against multiple diseases—such as Feline Viral Rhinotracheitis, Calicivirus, and Panleukopenia—in a single dose. This convenience appeals to pet owners by reducing the number of veterinary visits needed for comprehensive immunization, thereby enhancing adherence to vaccination schedules.
   
• Additionally, by offering protection against multiple diseases in a single dose, combined vaccines reduce the number of injections, which appeals to pet owners by lowering costs and minimizing stress for cats.
   
• These benefits have made combined vaccines the preferred choice, securing a significant share of the market.
   

Based on the duration of immunity, the cat vaccines market is segmented into 1 year, 3 years and other durations of immunity. The 1 year segment is expected to reach USD 1.3 billion in 2034.
 

• The 1-year immunity vaccine is widely used and accepted in veterinary practice. Its long-standing history of safety and efficacy has made it a trusted choice among both veterinarians and pet owners, ensuring its dominance in the market.
   
• The 1-year immunity duration aligns with the standard recommendations from veterinarians and regulatory bodies for core vaccinations. This has further fueled demand for vaccines with a 1-year immunity period.
   
• Moreover, vaccines with a 1-year immunity duration offer reliable and proven protection against common feline diseases, such as feline leukemia and panleukopenia.

The U.S. held a significant market share in the North American cat vaccines market and was valued at USD 378.7 million in 2024.
 

• The country’s large pet-owning population, alongside a strong veterinary infrastructure, contributes to the increasing demand for vaccines to protect cats from common infectious diseases.
   
• For instance, according to recent data from Worldostats, the U.S. with an estimated pet cat population of 90 million leading the global pet cat population.
   
• Additionally, the U.S. benefits from a well-established veterinary infrastructure, ensuring widespread access to veterinary clinics and pet care facilities, further bolstering the market growth.
   

Germany cat vaccines market is anticipated to witness significant growth over the forecast period.
 

• There is growing awareness among German pet owners about the importance of preventive care, leading to a shift toward regular vaccinations as part of responsible pet ownership.
   
• Furthermore, Germany’s strict animal health regulations, including mandatory rabies vaccinations in certain regions, have created a regulatory environment that encourages routine vaccine usage.
   

China is expected to experience growth at significant rate during the analysis period.
 

• As per the Cat Population 2024 by World Population Review, cat ownership is increasingly popular in China, with an estimated 53.1 million cats.
   
• Cats are highly valued in Chinese culture as symbols of fortune, which further boosts their appeal as companion animals. They are also favored for their low maintenance, quiet nature, and affordability, making them a preferred choice for many households.
   
• As the pet cat population grows, there is a rising need for vaccinations to protect against common feline diseases, contributing to the demand for cat vaccines in the country.
   

Brazil's cat vaccines market is projected to showcase lucrative growth during the forecast timeframe.
 

• The market is expected to experience lucrative growth due to a growing pet cat population, which currently stands at around 22.1 million, as per the Cat Population 2024 by World Population Review.
   
• The popularity of breeds like the Brazilian Shorthair and increasing awareness of pet health have driven demand for vaccinations to protect cats from common diseases.
   
• Additionally, expanding veterinary care infrastructure and the overall growth of Brazil's pet industry, including increased accessibility to pet care services, further contribute to the market's promising growth prospects during the forecast period.
   

Saudi Arabia cat vaccines market is poised to grow in the coming years.
 

• The Saudi government’s focus on improving veterinary care and animal welfare contributes to market expansion, along with growing investments in veterinary clinics and hospitals offering specialized services for pets.
   
• Additionally, the increasing availability of advanced vaccine options and a rising trend toward regular veterinary checkups are fueling market growth in Saudi Arabia.
   

Cat Vaccines Market Share

The market is highly competitive, with prominent players like Merck, Zoetis, Boehringer Ingelheim, and Elanco leading the industry. Key market strategies include expanding product portfolios, with a focus on innovative formulations such as combined vaccines, which provide protection against multiple diseases with a single dose, and vaccines offering extended immunity durations. Additionally, emerging markets with growing awareness of pet healthcare are becoming key areas for expansion.
 

Cat Vaccines Market Companies

Few of the prominent players operating in the cat vaccines industry include:

• Bioveta
• Boehringer Ingelheim
• Durvet
• Elanco
• Indian Immunologicals
• INTAS Animal Health
• Merck
• Spectra
• Virbac
• Zoetis
   

Cat Vaccines Industry News

• In September 2024, Merck Animal Health announced the expansion of its NOBIVAC NXT platform with the launch of the first and only RNA-particle technology vaccine for Feline Leukemia Virus. This innovation helped the company to strengthen its leadership in the feline vaccine market, offering a unique and advanced solution that meets the growing demand for effective feline leukemia prevention.
   
• In June 2024, Merck Animal Health announced the launch of its NOBIVAC NXT Rabies portfolio in Canada, which includes NOBIVAC NXT Feline-3 Rabies and NOBIVAC NXT Canine-3 Rabies, reaffirming the company's commitment to rabies protection. The company benefits by expanding its product offerings in Canada, enhancing its position as a leader in rabies prevention for both cats and dogs.
   

The cat vaccines market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Vaccine Type

• Modified/attenuated live
• Inactivated
• Other vaccine types

Market, By Disease Type

• Feline respiratory diseases
• Feline leukemia
• Feline panleukopenia (feline distemper)
• Feline rabies
• Other disease types

Market, By Route of Administration

• Injectables
• Intranasal

Market, By Component

• Combined vaccine
• Mono vaccine

Market, By Duration of Immunity

• 1 year
• 3 years
• Other durations of immunity

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea 
• Latin America
  • Brazil
  • Mexico
  • Argentina 
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE